109 related articles for article (PubMed ID: 12572868)
1. Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice.
Nakajima A; Wada K; Katayama K; Saubermann L; Osawa E; Nagase H; Ueno N; Matsuhashi N; Aburatani H
J Gastroenterol; 2002 Nov; 37 Suppl 14():62-6. PubMed ID: 12572868
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
[TBL] [Abstract][Full Text] [Related]
3. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
[TBL] [Abstract][Full Text] [Related]
5. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
[TBL] [Abstract][Full Text] [Related]
7. Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.
Fang K; Bruce M; Pattillo CB; Zhang S; Stone R; Clifford J; Kevil CG
Physiol Genomics; 2011 Jan; 43(1):43-56. PubMed ID: 20923862
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis.
Aoyagi Y; Nagata S; Kudo T; Fujii T; Wada M; Chiba Y; Ohtsuka Y; Yamashiro Y; Shimizu T; Ohkusa T
Pediatr Int; 2010 Oct; 52(5):729-34. PubMed ID: 20591056
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice.
Cao H; Liu J; Shen P; Cai J; Han Y; Zhu K; Fu Y; Zhang N; Zhang Z; Cao Y
J Agric Food Chem; 2018 Dec; 66(50):13133-13140. PubMed ID: 30472831
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
12. Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice.
Mannick EE; Cote RL; Schurr JR; Krowicka HS; Sloop GD; Zapata-Velandia A; Correa H; Ruiz B; Horswell R; Lentz JJ; Byrne P; Gastanaduy MM; Hornick CA; Liu Z
J Gastroenterol Hepatol; 2005 Mar; 20(3):371-80. PubMed ID: 15740479
[TBL] [Abstract][Full Text] [Related]
13. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
15. Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice.
Sánchez-Fidalgo S; Cárdeno A; Sánchez-Hidalgo M; Aparicio-Soto M; de la Lastra CA
J Nutr Biochem; 2013 Jul; 24(7):1401-13. PubMed ID: 23337347
[TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental colitis by intestinal mononuclear phagocytes.
Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
[TBL] [Abstract][Full Text] [Related]
17. [PPARgamma-gene therapy using an adenovirus vector for inflammatory bowel disease].
Nakajima A; Katayama K; Mayumi T
Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):309-16. PubMed ID: 14501166
[TBL] [Abstract][Full Text] [Related]
18. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
19. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.
Bassaganya-Riera J; Reynolds K; Martino-Catt S; Cui Y; Hennighausen L; Gonzalez F; Rohrer J; Benninghoff AU; Hontecillas R
Gastroenterology; 2004 Sep; 127(3):777-91. PubMed ID: 15362034
[TBL] [Abstract][Full Text] [Related]
20. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
